Dr. Sam A. Hout is a chartered chemical engineer and certified in business management by the American Production and Inventory Control Society (APICS). He also is a member of the International Society of Pharmaceutical Engineers (ISPE) and specializes in process engineering and business process improvement. He received his education and training in the UK (Ph.D. in Chemical Engineering, University of Bath) and in the United States (MBA, University of California). Dr. Hout is currently VP, of technical operations at KC Pharmaceuticals, California. For the past 20 years in drug manufacturing, he held the position of Sr. Director of Engineering, project management, and technology process transfers at SIEGFRIED Pharmaceuticals. Previously, Dr. Hout held the Sr. Manager of Engineering position at TEVA Pharmaceuticals, parenteral medicines in Irvine, California. These specialty divisions produced specialty drugs for hospital institutional markets worldwide. Before assuming the position at Teva, Dr. Hout was Director of Operations at PHENOMENEX, the leading global company in HPLC (High-Performance Liquid Chromatography) for drug separation and analysis. During the past thirty years, Hout has helped to guide leading companies in technical positions such as J&J, Medtronic, and Fischer Scientific in developing and producing oral solid dosage, medical devices, and diagnostic standards that combat disease and promote healthier lives. In working with a global market, Hout travels frequently throughout the United States, Europe, and the Far East. Major accomplishments include designing and constructing various plants, introducing many new products, optimization of several bio and pharmaceutical operations. Hout has consulted in many chemical engineering-affiliated industries.
